前列腺癌中的新型组织病理生物标志物:含义和前景
Paweł Kiełb1, Kamil Kowalczyk1, Adam Gurwin1
1University Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wrocław Medical University, 50-556 Wroclaw, Poland.
Biomedicines
|June 28, 2023
概括
像CD169巨细胞和PSMA这样的组织病理学生物标志物显示出改善前列腺癌 (PCa) 预后和治疗的前景. 这些标记物可以指导未来的免疫疗法和针对PCa患者的向放射性核素疗法.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 生物标志物发现发现
背景情况:
- 前列腺癌 (PCa) 是男性的主要癌症诊断,但在当前的检测和治疗策略中,组织病理生物标志物未得到充分利用.
- 通过改变生物标志物水平表示的前转移性利基的形成,对于PCa传播至关重要.
- 生物化学复发的现有危险因素包括淋巴结状况,PSA,格里森得分和瘤入侵特征.
研究的目的:
- 审查各种组织病理学生物标志物的潜力,以提高前列腺癌预后和治疗决策.
- 探索PCa中的生物标志物水平,瘤特征和临床结果之间的相关性.
- 假设这些生物标志物的未来应用在新型免疫疗法和向放射性核酸治疗中.
主要方法:
- 文献综述侧重于研究将基因病理生物标记水平与PCa特征和结果相关联的研究.
- 对特定生物标志物的分析,包括CD169巨细胞,神经素-1,科菲林-1,互白素-17,STAT3,LIMK1,CD15,AMACR,PSMA,Appl1,索尔提林,Syndcan-1和p63.
- 基于已识别的生物标志物作用,探索潜在的治疗应用.
主要成果:
- 几种组织病理学生物标志物与前列腺癌的瘤特征和临床结果有显著的相关性.
- 像CD169巨细胞和前列腺特异性膜抗原 (PSMA) 这样的特定生物标志物特别有前途.
- 鉴定到的生物标志物为改善预后准确性和治疗指导提供了潜力.
结论:
- 组织病理学生物标志物具有显著的潜力,可以完善前列腺癌的预后并个性化治疗策略.
- 这些标记物可以作为未来免疫治疗或向放射性核素辅助疗法的标.
- 对这些生物标志物的进一步研究可能会改善PCa患者的治疗和治疗结果.
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...